Dongkook Life Science Co., Ltd. (303810) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Dongkook Life Science Co., Ltd. (303810:KRX), powered by AI.

Current Price
₩2,400
P/E Ratio
8.7
Market Cap
76.8B
Sector
Healthcare
What is the Dongkook Life Science Co., Ltd. stock price forecast?

Dongkook Life Science Co., Ltd. is currently trading at ₩2,400. View real-time AI analysis on Alpha Lenz.

What is Dongkook Life Science Co., Ltd. insider trading activity?

View the latest insider trading data for Dongkook Life Science Co., Ltd. on Alpha Lenz.

What is Dongkook Life Science Co., Ltd.'s P/E ratio?

Dongkook Life Science Co., Ltd.'s P/E ratio is 8.7.

Dongkook Life Science Co., Ltd.

KRX · 303810
₩2,400+110(+4.80%)Market closedKRX regular session 09:00–15:30 KST
Ask about Dongkook Life Science Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Dongkook Life Science Co., Ltd. trades at a P/E of 8.7 (undervalued) with modest ROE of 7.3%.

Ask for details

Company Overview

Dongkook Life Science Co., Ltd. is a prominent entity in the pharmaceutical industry, focusing on the research, development, manufacture, and distribution of a wide array of healthcare products. Headquartered in South Korea, the company aims to improve health and well-being by offering innovative solutions in pharmaceuticals, medical devices, and health supplements. Notable for its comprehensive approach to healthcare, Dongkook Life Science has established itself in various segments, serving hospitals, clinics, pharmacies, and end consumers. Its operations encompass both domestic and international markets, reflecting its significant role in global health advancement. Strategic investments in new technologies and active research programs underscore its commitment to enhancing therapeutic options and accessibility.

CEO박재원
SectorHealthcare
IndustryMedical Instruments & Supplies
0

Company Statistics

FY 2025

Profile

₩76,761,936,000Market Cap
₩130,343,747,510Revenue
31.98MShares Out
0Employees

Margins

25.32%Gross
16.08%EBITDA
10.01%Operating
8.31%Pre-Tax
6.64%Net

Valuation

8.73P/E
0.58P/B
0.58EV/Sales
5.37EV/EBITDA
-14.37P/FCF

Growth (CAGR)

6.72%Rev 3Yr
3.53%Rev 5Yr
27.93%Op Inc 3Yr
9.13%Op Inc 5Yr
26.88%Net Inc 3Yr
14.21%Net Inc 5Yr

Returns

4.23%ROA
7.32%ROE
7.14%ROIC

Financial Health

₩1,959,250,080Cash & Cash Equivalents
₩84,302,103,390Net Debt
65.67%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Dongkook Life Science Co., Ltd. (ticker: 303810) is a company listed on KRX in the Healthcare sector (Medical Instruments & Supplies). Market cap is $76.8B.

The current price is ₩2,400 with a P/E ratio of 8.73x and P/B of 0.58x.

ROE is 7.32% and operating margin is 10.01%. Annual revenue is $130.3B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Dongkook Life Science Co., Ltd. (303810) Stock Forecast 2026 ₩2,400 — Price, Financials & Analyst Targets | Alpha Lenz